noscript

News and Announcements

SUDA Annual Update 2016; IP Filed & Major Deal Signed

  • Published January 19, 2017 5:00PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

SUDA Ltd (ASX:SUD)  is a drug delivery company headquartered in Perth, WA. The Company is developing low-risk oral sprays using novel formulations of existing pharmaceuticals. The many potential benefits of administering drugs through the cheeks, tongue, gums to include ease of use, lower dosage, reduced side effects and faster response time. During the year, the Company completed an array of achievements;

  • Completed the development and filed IP for its novel penetration enhancing technology.
  • November 2016, SUDA announced a major deal with Eddingpharm, a leading Chinese pharmaceutical company.
  • SUDA’s ZolpiMistÔ oral spray for the treatment of insomnia in China. The total deal value could exceed $34 million in upfront, milestone and royalty payments.

Active discussions are ongoing with approximately 60 pharmaceutical companies.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now